Azetidine → HCID 58109138, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[CH:12][C:11]([C@@H:14]([N:16]3[CH2:21][CH2:20][C@@:19]([C:25]4[CH:30]=[CH:29][C:28]([F:31])=[CH:27][CH:26]=4)([CH2:22][CH2:23]O)[O:18][C:17]3=[O:32])[CH3:15])=[CH:10][CH:9]=2)=[CH:4][CH:3]=1.[NH:33]1[CH2:36][CH2:35][CH2:34]1>>[N:33]1([CH2:23][CH2:22][C@@:19]2([C:25]3[CH:26]=[CH:27][C:28]([F:31])=[CH:29][CH:30]=3)[O:18][C:17](=[O:32])[N:16]([C@H:14]([C:11]3[CH:10]=[CH:9][C:8]([C:5]4[CH:6]=[CH:7][C:2]([F:1])=[CH:3][CH:4]=4)=[CH:13][CH:12]=3)[CH3:15])[CH2:21][CH2:20]2)[CH2:36][CH2:35][CH2:34]1Participants
3
Procedure
The title compound was prepared from (S)-3-((S)-1-(4′-fluorobiphenyl-4-yl)ethyl)-6-(4-fluorophenyl)-6-(2-hydroxyethyl)-1,3-oxazinan-2-one following procedures analogous to those described in Example 178 using azetidine in Step 2. LC-MS Method 2 tR=1.193 min, m/z=477.2; 1H NMR (CD3OD) 1.57 (d, 3H), 2.16 (m, 2H), 2.26 (m, 2H), 2.48 (m, 1H), 2.50 (m, 2H), 3.01 (m, 1H), 3.11 (m, 1H), 3.25 (m, 1H), 3.40 (m, 2H), 4.20 (m, 2H), 5.59 (m, 1H), 7.08 (d, 2H), 7.14 (m, 4H), 7.33 (m, 2H), 7.37 (m, 2H), 7.54 (m, 2H).
Sources & evidence
- ORD record
- ord-49935207b01748e9872010aa7fa55d31
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08575156B2
Reaction notes
Loading…